TORONTO, ON / ACCESSWIRE / April 8, 2015 / CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm Solutions" or the "Company") today announced that it will issue 214,286 common shares to a consultant organization under a sales and marketing agreement previously announced on January 30, 2015. Under the agreement, the consultant group will introduce the Company's HeartCheck(TM) ECG products and related SMART Monitoring ECG reading services into drug chains, mass retailers, club retailers, grocery retailers and distributors' head offices within the United States.
Shares will be issued at a deemed price of $0.07 per share as payment of the $15,000 consulting fee as a second milestone for services provided under the agreement from January 1, 2015 to March 31, 2015. The share issuance is subject to the approval of the TSX Venture Exchange and applicable securities laws. From April 1, 2015, the consultant will be provided commission fees generated from the sales of HeartCheck(TM) ECG devices and recurrent SMART Monitoring ECG services use.
For more about the Company's HeartCheck(TM) products and services and retail pharmacy sales can be seen at www.theheartcheck.com.
About CardioComm Solutions
CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The Company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions is headquartered in Toronto, Ontario, Canada, with offices in Victoria, B.C.
FOR FURTHER INFORMATION PLEASE CONTACT:
Etienne Grima, Chief Executive Officer
1-877-977-9425 x 227
investorrelations@cardiocommsolutions.com
www.cardiocommsolutions.com
Forward-looking statements
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: CardioComm Solutions, Inc.
